ifosfamide has been researched along with Nasopharyngeal Neoplasms in 15 studies
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the toxicity and efficacy of concurrent chemoirradiation with cisplatin followed by adjuvant ifosfamide, 5-fluorouracil and leucovorin in patients with stage IVb nasopharyngeal carcinoma (NPC) PATIENTS AND METHODS: Between October 1998 and August 2001, 35 Chinese patients with stage IVb NPC (N3a:12, N3b:23) were treated with by concurrent chemoirradiation using cisplatin 100 mg/m2 on days 1, 22, and 43 of radiotherapy, followed by adjuvant chemotherapy with 1." | 9.11 | A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma. ( Au, GK; Chua, DT; Sham, JS, 2004) |
| "To evaluate the efficacy and safety of gemcitabine combined with ifosfamide (GI regimen)in patients with recurrent or metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy." | 7.81 | [Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy]. ( Dong, M; Gui, L; He, X; Hu, S; Jia, B; Liu, P; Qin, Y; Yang, J; Yang, S; Zhang, C; Zhou, S, 2015) |
| "To evaluate the toxicity and efficacy of concurrent chemoirradiation with cisplatin followed by adjuvant ifosfamide, 5-fluorouracil and leucovorin in patients with stage IVb nasopharyngeal carcinoma (NPC) PATIENTS AND METHODS: Between October 1998 and August 2001, 35 Chinese patients with stage IVb NPC (N3a:12, N3b:23) were treated with by concurrent chemoirradiation using cisplatin 100 mg/m2 on days 1, 22, and 43 of radiotherapy, followed by adjuvant chemotherapy with 1." | 5.11 | A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma. ( Au, GK; Chua, DT; Sham, JS, 2004) |
| "To evaluate the efficacy and safety of gemcitabine combined with ifosfamide (GI regimen)in patients with recurrent or metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy." | 3.81 | [Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy]. ( Dong, M; Gui, L; He, X; Hu, S; Jia, B; Liu, P; Qin, Y; Yang, J; Yang, S; Zhang, C; Zhou, S, 2015) |
| "Ifosfamide was administered intravenously at the dose of 1,200 mg/m2 from day 1 to day 5 with uroprotection of Mesna in fusion at 0, 3, and 6 hours following initiation of IFO." | 2.70 | [Preliminary results of ifosfamide and doxorubicin regimen in treatment of patients with recurrent and metastatic nasopharyngeal carcinoma]. ( Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Teng, XY; Zhou, ZM, 2002) |
| "Radiation-induced osteosarcomas are a recognized complication of radiation therapy." | 2.53 | Radiation-induced osteosarcoma of the skull base after radiation therapy in a patient with nasopharyngeal carcinoma: a case report and review of the literature. ( Benjaafar, N; Echchikhi, Y; Kebdani, T; Loughlimi, H; Touil, A, 2016) |
| "Ifosfamide (IFO) has demonstrated activity in recurrent/metastatic squamous cell head and neck carcinoma with an overall response rate of 24-26%." | 2.42 | Ifosfamide in the treatment of head and neck cancer. ( Airoldi, M; Bumma, C; Cortesina, G; Giordano, C; Pedani, F, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Muramatsu, J | 1 |
| Takada, K | 1 |
| Sugita, S | 1 |
| Tsuchiya, T | 1 |
| Yamamoto, K | 1 |
| Takagi, M | 1 |
| Murase, K | 1 |
| Ameda, S | 1 |
| Arihara, Y | 1 |
| Miyanishi, K | 1 |
| Sakata, KI | 1 |
| Kato, J | 1 |
| Jacobson, C | 1 |
| LaCasce, A | 1 |
| Hu, S | 1 |
| He, X | 1 |
| Dong, M | 1 |
| Jia, B | 1 |
| Zhou, S | 1 |
| Yang, J | 1 |
| Yang, S | 1 |
| Zhang, C | 1 |
| Liu, P | 1 |
| Qin, Y | 1 |
| Gui, L | 1 |
| Echchikhi, Y | 1 |
| Loughlimi, H | 1 |
| Touil, A | 1 |
| Kebdani, T | 1 |
| Benjaafar, N | 1 |
| Ghosh-Laskar, S | 1 |
| Agarwal, JP | 1 |
| Mohindra, P | 1 |
| Sengar, M | 1 |
| Vyas, S | 1 |
| Pai, VR | 1 |
| Budrukkar, A | 1 |
| Pai, P | 1 |
| D'Cruz, AK | 1 |
| Dinshaw, KA | 1 |
| Dede, DS | 1 |
| Aksoy, S | 2 |
| Cengiz, M | 2 |
| Gullu, I | 2 |
| Altundag, K | 2 |
| Huang, HQ | 1 |
| Zhou, ZM | 1 |
| Li, YH | 1 |
| Jiang, WQ | 1 |
| He, YJ | 1 |
| Teng, XY | 1 |
| Guan, ZZ | 1 |
| Chen, C | 1 |
| Shu, HK | 1 |
| Goldwein, JW | 1 |
| Womer, RB | 1 |
| Maity, A | 1 |
| Airoldi, M | 1 |
| Cortesina, G | 1 |
| Giordano, C | 1 |
| Pedani, F | 1 |
| Bumma, C | 1 |
| Chua, DT | 2 |
| Sham, JS | 2 |
| Au, GK | 2 |
| Altundag, O | 1 |
| Ozyar, E | 1 |
| Yalcin, S | 1 |
| Akyol, F | 1 |
| Stein, ME | 2 |
| Ruff, P | 1 |
| Weaving, A | 1 |
| Fried, J | 1 |
| Bezwoda, WR | 1 |
| Drumea, K | 1 |
| Chou, CW | 1 |
| Liu, JM | 1 |
| Wu, MF | 1 |
| Li, AF | 1 |
| Tie, CM | 1 |
| Chi, KH | 1 |
| Kwong, DL | 1 |
| Choy, D | 1 |
3 reviews available for ifosfamide and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Radiation-induced osteosarcoma of the skull base after radiation therapy in a patient with nasopharyngeal carcinoma: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Diplopia; Doxorubicin; | 2016 |
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 2003 |
Ifosfamide in the treatment of head and neck cancer.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamo | 2003 |
4 trials available for ifosfamide and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
[Preliminary results of ifosfamide and doxorubicin regimen in treatment of patients with recurrent and metastatic nasopharyngeal carcinoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Ifosfamide; Male | 2002 |
A concurrent chemoirradiation with cisplatin followed by adjuvant chemotherapy with ifosfamide, 5-fluorouracil, and leucovorin for stage IV nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisp | 2004 |
A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined | 1996 |
A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Follow-Up Studies; Huma | 2000 |
8 other studies available for ifosfamide and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Complete Response Induced by Concurrent Chemoradiotherapy in a Patient with NUT Carcinoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Hum | 2022 |
How I treat Burkitt lymphoma in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabin | 2014 |
[Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy].
Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytid | 2015 |
Ifosfamide-based chemotherapy in locoregionally advanced nasopharyngeal cancer: evaluation of its role as neoadjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined M | 2009 |
Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamo | 2012 |
Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with Cisplatin-based chemotherapy.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agen | 2004 |
Ifosfamide/cisplatin-based chemotherapy in metastatic undifferentiated nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; | 1997 |
Prolonged survival in a nasopharyngeal carcinoma patient with multiple metastases: a case report and review of the literature.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 1997 |